A safer future isn’t just something we wish for.
We’re creating it.
TO DELIVER NEXT-GEN ARRAYS FOR BETTER HEALTH AND SAFETY.
- PathogenDx Is Headed To AAFP: Introducing SeroXMore »
This year, PathogenDx is proud to sponsor the Arkansas Association of Food Protection (AAFP) Conference, and introduce the Future of Safe in Poultry with its SeroX assay. Developed on our highly multiplexed and patented D3 Array™, PathogenDx now delivers ultra-rapid Salmonella detection and Serotyping in a single well reaction, at a fraction of the cost, time and effort of conventional methods.
INTRODUCING SEROX
This new Assay delivers advanced gene detection of Salmonella and all currently proposed and future USDA FSIS serotypes. SeroX ensures the simplified workflow, agility and cost savings the poultry industry needs to optimize their production lots and ensure safety and quality. Benefits include:- Industry-leading test turnaround time
- Best-in-Class cost per sample
- Minimize hold times and storage costs
- Ensure freshness of product and shelf life
- Future-proof testing—detect today’s Serotypes and add tomorrow’s
Stop by and see us at AAFP! In the meantime, you can learn more at pathogendx.com/food.
- Introducing D3 Array™-UTI to the Executive War College
Today, a wide range of urinary tract conditions are considered either complex or recurrent, creating the need for more complete and rapid insight.
Introducing PathogenDx D3 Array™-UTI to Executive War College. This is a fast multiplexed testing solution for urinary pathogen detection run simultaneously with antibiotic resistance gene markers. This novel highly multiplexed UTI assay provides a scalable, low cost solution in a single test with results in under 6.5 hours.
Test for 26 causative pathogens + 12 Antibiotic Resistance Genes in a single test, with qualitative detection and quantification in the same sample reaction. This multiplexed assay delivers unrivaled insight in a single test, with same-shift results.
Learn more at https://pathogendx.com/uti/